Director of Communications

Tracy Lessor brings more than 25 years of experience in science and corporate communications across the biotech and pharmaceutical industries. She previously served as Executive Director of Corporate Affairs and Investor Relations at Schrödinger, where she led all external and internal communications. At Amgen, she directed global communications for the biosimilars division, including the launch of the company’s first five biosimilar medicines. Earlier in her career, she spent more than a decade as Senior Vice President at Feinstein Kean Healthcare/Ogilvy, shaping strategy and storytelling for breakthrough scientific advances. She earned a Ph.D. in molecular and cell biology at the University of Medicine Greenebaum Cancer Center, an M.B.A. at Babson College, and is a board-certified Editor of the Life Sciences (ELS).